http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102312414-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2020-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102312414-B1 |
| titleOfInvention | Composition for preventing or treating cancer comprising TRAIL-secreting mesenchymal stem cells and compound C |
| abstract | The present invention relates to a pharmaceutical composition, kit, or anticancer adjuvant for preventing or treating cancer comprising mesenchymal stem cells and compound C secreting TRAIL. When the mesenchymal stem cells secreting TRAIL of the present invention and compound C are combined, the expression of proteins related to apoptosis of cancer cells is reduced compared to the case of treating TRAIL-secreting mesenchymal stem cells or compound C alone, respectively. It is possible to significantly increase apoptosis of cancer cells by increasing and reducing the expression of anti-apoptotic proteins, thereby obtaining a high anticancer effect. |
| priorityDate | 2020-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.